Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Discover timing cues for using tactical allocation with index funds retirement to potentially enhance returns without sacrificing core diversification.
23,450 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
This guide shows investors how to interpret earnings transcripts for natural gas services. It covers key metrics, rea...
The crypto market has cooled from its peaks, but two names consistently draw attention: Ethereum and Solana. This gui...
H&R Block’s Q3 results set the tone for block (hrb) 2026 earnings. This guide breaks down the numbers, strategy, and ...
As the first-quarter report for Innovate lands, investors eye more than just the top line. This guide breaks down wha...
Curious about XRP’s future? This article lays out a practical 5-year forecast with three scenarios and clear steps yo...
Quantum computing is entering a new era of investment potential. This guide breaks down how to pick what best quantum...
A boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
As stocks climb, a warning from the former chair of the Federal Reserve signals risk ahead. This guide explains the t...
Quantum tech is finally moving from labs to portfolios. This article breaks down why d-wave quantum shares soaring ha...
A risk-off mood is weighing on major cryptos as ETF redemptions surge. This guide breaks down the forces at work and ...
A large insider stake in Veris Residential stock signals conviction from an established manager. This article explain...